Technology News Journal
SEE OTHER BRANDS

Global take on science and technology news

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology News Journal.

Gov. Ivey awards grants to help north Alabama K-12 students access science and technology programs, computer equipment

Gov. Ivey awards grants to help north Alabama K-12 students access science and technology programs, computer equipment

MONTGOMERY— Gov. Kay Ivey announced $784,991 in Appalachian Regional Commission grants to support programs and purchase new equipment that will help students in six public school systems learn skills and technology needed for success in the...

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts

– Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule – – Verrica to receive a $10 million milestone payment from Torii in cash upon the approval of YCANTH® (TO-208 in...

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)

REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical...

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

FDA 510(k) application submitted to allow marketing of the ARC-EX® System for home use in the United States CE Mark application filed with notified body to enable commercialization of the ARC-EX System in the European Union and other countries...

New Membrane Technology Could Expand Access to Water for Agricultural and Industrial Use

New Membrane Technology Could Expand Access to Water for Agricultural and Industrial Use

Key Takeaways Approximately 40 percent of the U.S. water supply comes from underground aquifers but much of it is too salty for many human uses. By sufficiently treating brackish groundwater to separate salts and other contaminants, the U.S. could...

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

LONDON, June 30, 2025 (GLOBE NEWSWIRE) -- Portal Biotech, a pioneering biotechnology company headquartered in London, today announced a $35 million Series A raise, representing one of Europe's largest investments into a life sciences tools...

K-Beauty’s PDRN Craze: Rejuveon PDRN Cream Sets a New Standard with Medical-Grade Skin Regeneration Formula

K-Beauty’s PDRN Craze: Rejuveon PDRN Cream Sets a New Standard with Medical-Grade Skin Regeneration Formula

Rejuveon PDRN Cream merges clinical science with K-beauty elegance, delivering 99.99% medical-grade skin regeneration and post-procedure recovery NEW YORK, NY, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- K-beauty has once again captured...

Agooran Launches Strongly on Plouton Exchange, Incredible Short-Term Growth as Medical Technology Sector Experiences Strategic Surge

Agooran Launches Strongly on Plouton Exchange, Incredible Short-Term Growth as Medical Technology Sector Experiences Strategic Surge

New York, NY, June 30, 2025 (GLOBE NEWSWIRE) -- The global medical technology sector is witnessing a phase of explosive growth. Recently, the flagship global digital healthcare project Agooran (AOO) officially launched on Plouton Exchange. After...

Total number of shares and voting rights in Zealand Pharma as of June 30, 2025

Total number of shares and voting rights in Zealand Pharma as of June 30, 2025

Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

CEO of Weber Legal Nurse Consulting Launches Daylong Classes for Medical Professionals Aimed at Reducing Medical Errors

CEO of Weber Legal Nurse Consulting Launches Daylong Classes for Medical Professionals Aimed at Reducing Medical Errors

RN and Legal Nurse Consultant Silvia Aninye’s Goal is to Improve Communications and Practices in the Healthcare Field to Ensure Fewer Medical Mistakes. LOS ANGELES, CA, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- Weber Legal Nurse...

CodeMonkey’s AP Computer Science Principles (CSP) Course Approved by the College Board

CodeMonkey’s AP Computer Science Principles (CSP) Course Approved by the College Board

SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- CodeMonkey, a leading provider of gamified coding education for K-12 students, is proud to announce the launch of its brand-new Advanced Placement (AP) Computer Science Principles (CSP) course,...

Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat

Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat

– The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily demonstrated clinically meaningful reductions in...

Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

No treatment-related neuropsychiatric events seen to date in SAD portion of Phase 1 MAD study on track for completion in Q3 2025 NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a...

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

CHATHAM, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company, today announced that it will be added to the broad-market Russell 3000® Index,...

Chart Industries to Announce Second Quarter 2025 Results on July 31

Chart Industries to Announce Second Quarter 2025 Results on July 31

ATLANTA, June 30, 2025 (GLOBE NEWSWIRE) -- Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in energy and industrial gas solutions, has scheduled a conference call for Thursday, July 31, 2025 at 8:30 a.m. ET to discuss its second...

Peak Neuro LLC Unveils Groundbreaking Research on Neural Entrainment at 2025 Annual Science of Consciousness Conference

Peak Neuro LLC Unveils Groundbreaking Research on Neural Entrainment at 2025 Annual Science of Consciousness Conference

Peak Neuro LLC's Audio Entrainment enhances neural plasticity and cognitive performance, boosting learning, focus, emotional regulation, and adaptive readiness. RESTON, VA, UNITED STATES, June 30, 2025 /⁨EINPresswire.com⁩/ -- Peak Neuro LLC is...

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

DUBLIN, June 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S. Court of Appeals for the...

Tilde Sciences Announces Availability Of VECAMYL™ (Mecamylamine) With Exclusive Distribution Through Optime Care Specialty Pharmacy

Tilde Sciences Announces Availability Of VECAMYL™ (Mecamylamine) With Exclusive Distribution Through Optime Care Specialty Pharmacy

JERSEY CITY, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tilde Sciences LLC (“Tilde”), a U.S.–based biopharmaceutical company dedicated to developing therapies for rare diseases with significant unmet need, today announced the nationwide availability...

Orangekloud Signs MOU for Development of Specialized LLM for Software Engineering and Application Development

Orangekloud Signs MOU for Development of Specialized LLM for Software Engineering and Application Development

SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (Nasdaq: ORKT) (“Orangekloud” or “the Company”), a Singapore-based technology company offering the eMOBIQ® No-Code platform for development of mobile applications, today...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service